Patent details

EP3750531 Title: TUDCA AND SODIUM PHENYLBUTYRATE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

Basic Information

Publication number:
EP3750531
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP201693991
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TUDCA AND SODIUM PHENYLBUTYRATE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
French Title of Invention:
TUDCA ET PHÉNYLBUTYRATE DE SODIUM POUR UTILISATION DANS LE TRAITEMENT DES MALADIES NEURODÉGÉNÉRATIVES
German Title of Invention:
TUDCA UND NATRIUMPHENYLBUTYRAT ZUR VERWENDUNG BEI DER BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
24/02/2014
Grant date:
18/09/2024
EP Publication Date:
16/12/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/09/2024
EP B1 Publication Date:
18/09/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/02/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/09/2024
 
 

Name:
Amylyx Pharmaceuticals Inc.
Address:
43 Thorndike St, Cambridge, MA 02141, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/11/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KLEE,, Justin
Address:
United States (US)

2

Name:
COHEN,, Joshua B.
Address:
United States (US)

Priority

1

Priority Number:
201361804690 P
Priority Date:
24/03/2013
Priority Country:
United States (US)

2

Priority Number:
201314140083
Priority Date:
24/12/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/19; A61K 31/195; A61K 31/185; A61P 25/28; A61P 25/00; A61K 31/575; A61K 31/192;

Publication

European Patent Bulletin

1

Issue number:
202438
Publication date:
18/09/2024
Description:
Grant (B1)

2

Issue number:
202443
Publication date:
23/10/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
26/11/2024 Power Of Attorney 1
26/11/2024 Outgoing Correspondence 1